Seven Up For Sanofi and Regeneron With Dupixent CSU Approval

 
• By Kevin Grogan
  
Crowns
Dupixent is about to add another indication to its roster • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from New Products